TY - JOUR
T1 - Active assistance technology reduces glycosylated hemoglobin and weight in individuals with type 2 diabetes
T2 - Results of a theory-based randomized trial
AU - Orsama, Anna-Leena
AU - Lähteenmäki, Jaakko
AU - Harno, Kari
AU - Kulju, Minna
AU - Wintergerst, Eva
AU - Schachner, Holly
AU - Stenger, Pat
AU - Leppänen, Juha
AU - Kaijanranta, Hannu
AU - Salaspuro, Ville
AU - Fisher, William A.
PY - 2013
Y1 - 2013
N2 - Background: Type 2 diabetes is an individual health challenge requiring ongoing self-management. Remote patient reporting of relevant health parameters and linked automated feedback via mobile telephone have potential to strengthen self-management and improve outcomes. This research involved development and evaluation of a mobile telephone-based remote patient reporting and automated telephone feedback system, guided by health behavior change theory, aimed at improving self-management and health status in individuals with type 2 diabetes. Subjects and Methods: This research comprised a randomized controlled trial. Inclusion criteria were diagnosis of type 2 diabetes, elevated glycosylated hemoglobin (HbA1c) levels (range, 6.5–11%) or use of oral diabetes medication, and 30–70 years of age. Intervention subjects (n=24) participated in remote patient reporting of health status parameters and linked health behavior change feedback. Control participants (n=24) received standard of care including diabetes education and healthcare provider counseling. Patients were followed for approximately 10 months. Results: Intervention participants achieved, compared with controls and controlling for baseline, a significantly greater mean reduction in HbA1c of −0.40% (95% confidence interval [CI] −0.67% to −0.14%) versus 0.036% (95% CI −0.23% to 0.30%) (P<0.03) and significantly greater weight reduction of −2.1 kg (95% CI −3.6 to −0.6 kg) versus 0.4 kg (95% CI −1.1 to 1.9 kg). Nonsignificant trends for greater intervention compared with control improvement in systolic and diastolic blood pressure were observed. Conclusions: Sophisticated information technology platforms for remote patient reporting linked with theory-based health behavior change automated feedback have potential to improve patient outcomes in type 2 diabetes and merit scaled-up research efforts.
AB - Background: Type 2 diabetes is an individual health challenge requiring ongoing self-management. Remote patient reporting of relevant health parameters and linked automated feedback via mobile telephone have potential to strengthen self-management and improve outcomes. This research involved development and evaluation of a mobile telephone-based remote patient reporting and automated telephone feedback system, guided by health behavior change theory, aimed at improving self-management and health status in individuals with type 2 diabetes. Subjects and Methods: This research comprised a randomized controlled trial. Inclusion criteria were diagnosis of type 2 diabetes, elevated glycosylated hemoglobin (HbA1c) levels (range, 6.5–11%) or use of oral diabetes medication, and 30–70 years of age. Intervention subjects (n=24) participated in remote patient reporting of health status parameters and linked health behavior change feedback. Control participants (n=24) received standard of care including diabetes education and healthcare provider counseling. Patients were followed for approximately 10 months. Results: Intervention participants achieved, compared with controls and controlling for baseline, a significantly greater mean reduction in HbA1c of −0.40% (95% confidence interval [CI] −0.67% to −0.14%) versus 0.036% (95% CI −0.23% to 0.30%) (P<0.03) and significantly greater weight reduction of −2.1 kg (95% CI −3.6 to −0.6 kg) versus 0.4 kg (95% CI −1.1 to 1.9 kg). Nonsignificant trends for greater intervention compared with control improvement in systolic and diastolic blood pressure were observed. Conclusions: Sophisticated information technology platforms for remote patient reporting linked with theory-based health behavior change automated feedback have potential to improve patient outcomes in type 2 diabetes and merit scaled-up research efforts.
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84893336716&partnerID=MN8TOARS
U2 - 10.1089/dia.2013.0056
DO - 10.1089/dia.2013.0056
M3 - Article
SN - 1520-9156
VL - 15
SP - 662
EP - 669
JO - Diabetes Technology and Therapeutics
JF - Diabetes Technology and Therapeutics
IS - 8
ER -